chr14-60648804-T-G
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PM5PP3_ModeratePP5
The NM_005982.4(SIX1):c.386A>C(p.Tyr129Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y129C) has been classified as Pathogenic.
Frequency
Consequence
NM_005982.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIX1 | NM_005982.4 | c.386A>C | p.Tyr129Ser | missense_variant | 1/2 | ENST00000645694.3 | NP_005973.1 | |
SIX1 | XM_017021602.3 | c.386A>C | p.Tyr129Ser | missense_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIX1 | ENST00000645694.3 | c.386A>C | p.Tyr129Ser | missense_variant | 1/2 | NM_005982.4 | ENSP00000494686.1 | |||
SIX1 | ENST00000554986.2 | c.42-2227A>C | intron_variant | 3 | ENSP00000452700.2 | |||||
SIX1 | ENST00000553535.2 | n.249-2227A>C | intron_variant | 3 | ||||||
SIX1 | ENST00000555955.3 | n.1198-2227A>C | intron_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Branchiootic syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center of Genomic medicine, Geneva, University Hospital of Geneva | Jun 01, 2018 | - - |
Branchiootic syndrome 3;C1854594:Autosomal dominant nonsyndromic hearing loss 23 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center of Genomic medicine, Geneva, University Hospital of Geneva | Jun 01, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 13, 2018 | Variant classified as Uncertain Significance - Favor Pathogenic. The p.Tyr129Ser variant in SIX1 has not been previously reported in individuals with hearing lo ss or branchio-oto-renal syndrome. However, a different pathogenic missense var iant at the same amino acid position (c.386A>G, p.Tyr129Cys) has been reported i n 3 probands with branchio-oto-renal syndrome, segregated in >10 affected indivi duals from one family, and in vitro functional evidence supported a deleterious effect of the variant (Ito 2006, Noguchi 2011, Patrick 2009, Ruf 2003, Ruf 2004) . The p.Tyr129Ser variant was absent from population databases. Computational prediction tools and conservation analyses suggest that the p.Tyr129Ser variant may impact the protein, though this information is not predictive enough to dete rmine pathogenicity. In summary, while there is some suspicion for a pathogenic role, the clinical significance of this variant is uncertain. ACMG/AMP criteria applied: PM2; PM5; PP3. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at